Carlson Capital’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,222
| Closed | -$246K | – | 165 |
|
|
2023
Q4 | $246K | Sell |
3,222
-334
| -9% | -$25.5K | 0.02% | 116 |
|
|
2023
Q3 | $299K | Hold |
3,556
| – | – | 0.02% | 126 |
|
|
2023
Q2 | $495K | Sell |
3,556
-111
| -3% | -$15.4K | 0.04% | 109 |
|
|
2023
Q1 | $1.06M | Sell |
3,667
-689
| -16% | -$198K | 0.1% | 98 |
|
|
2022
Q4 | $1.14M | Sell |
4,356
-111
| -2% | -$29K | 0.09% | 102 |
|
|
2022
Q3 | $1.2M | Buy |
4,467
+228
| +5% | +$61K | 0.09% | 99 |
|
|
2022
Q2 | $1.42M | Buy |
4,239
+762
| +22% | +$255K | 0.1% | 107 |
|
|
2022
Q1 | $2.13M | Buy |
3,477
+366
| +12% | +$224K | 0.15% | 121 |
|
|
2021
Q4 | $1.89M | Buy |
3,111
+1,510
| +94% | +$917K | 0.11% | 120 |
|
|
2021
Q3 | $1.57M | Buy |
1,601
+468
| +41% | +$459K | 0.08% | 140 |
|
|
2021
Q2 | $1.69M | Buy |
1,133
+244
| +27% | +$365K | 0.08% | 135 |
|
|
2021
Q1 | $2.39M | Buy |
889
+333
| +60% | +$895K | 0.09% | 139 |
|
|
2020
Q4 | $1.1M | Buy |
+556
| New | +$1.1M | 0.04% | 142 |
|